We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
387 hedge funds and large institutions have $13.7B invested in Madrigal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 85 funds opening new positions, 137 increasing their positions, 113 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
107% more first-time investments, than exits
New positions opened: 85 | Existing positions closed: 41
28% more capital invested
Capital invested by funds: $10.7B → $13.7B (+$2.99B)
21% more repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 113
19% more call options, than puts
Call options by funds: $323M | Put options by funds: $271M
10% more funds holding
Funds holding: 352 → 387 (+35)
1.57% less ownership
Funds ownership: 105.34% → 103.78% (-1.6%)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
Holders
387
Holders Change
+35
Holders Change %
+9.94%
% of All Funds
4.71%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.16%
New
85
Increased
137
Reduced
113
Closed
41
Calls
$323M
Puts
$271M
Net Calls
+$52.6M
Net Calls Change
-$16.2M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$87.7M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$79M |
| 3 |
AC
Armistice Capital
New York
|
+$74.4M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$72.9M |
| 5 |
Alkeon Capital Management
New York
|
+$61.3M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$132M |
| 2 |
PC
Paulson & Co
New York
|
-$102M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$58.6M |
| 4 |
Morgan Stanley
New York
|
-$50.7M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$42.8M |
